New Proprietary Surface Coatings Create More Physiologically-relevant Cellular Assays

WOBURN, Mas.–SRU Biosystems today announced the expansion of its line of plate-based BIND® Biosensors. SRU Biosystems’ plate-based BIND® Biosensor line now includes microplates with the following surfaces: unmodified titanium oxide, surfaces for biochemical applications, streptavidin, and a new line of two proprietary extracellular matrix coatings for cell-based assays. Biosensors are available in 16-, 96-, 384-, 384 low volume- and 1536-well formats, addressing the breadth of throughput requirements. The expansion brings with it optimized performance for biochemical and cell-based applications as well as throughput flexibility.

As science advances, researchers are demanding more physiologically relevant assays. “Our R&D efforts, and those of our customers, have found that using the right extracellular matrix for a given cell type is critical for generating a robust response to GPCR, RTK, and ion channel ligands on recombinant or native cells,” said Mann Shoffner, Director of Sales and Marketing at SRU Biosystems. “SRU scientists have developed unique BIND® Biosensors which promote ideal cellular attachment for most cell types thereby creating more relevant assay microenvironments for cell signaling studies. These biosensors are directly increasing the effectiveness of our customers’ discovery efforts.”

“SRU has found that the profile of label-free users has diversified to include researchers across academia and industry with an ever-growing list of applications,” says Rick Wagner, CEO of SRU Biosystems. “SRU has focused on building our entire platform, including BIND Readers and Biosensors, to provide superior label-free BIND tools to the widest audience possible.”

About SRU Biosystems

SRU Biosystems, Inc., is a life science company offering novel, label-free tools used to answer important biological questions in biomedical research and pharmaceutical drug discovery. SRU’s label-free BIND® Technology can rapidly analyze the interactions of genomic, peptide, antibody or small molecule compound libraries against a wide range of cellular and biochemical targets. www.srubiosystems.com